Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Pharmacies in the HIV Prevention and Care Continuums: A Systematic Review
Natalie D. Crawford, Sky Myers, Henry N. Young, et al.
AIDS and Behavior (2021) Vol. 25, Iss. 6, pp. 1819-1828
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
Elzette Rousseau, Robin Julies, Ndumiso Madubela, et al.
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 6, pp. 500-507
Open Access | Times Cited: 50
Involving community pharmacists in interprofessional collaboration in primary care: a systematic review
Morgane Angibaud, Maud Jourdain, Solene Girard, et al.
BMC Primary Care (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions
Stephanie D. Roche, Daniel Were, Natalie D. Crawford, et al.
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 3, pp. 116-130
Open Access | Times Cited: 5
The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review
Ali Ahmed, Muhammad Saqlain, Maria Tanveer, et al.
BMC Health Services Research (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Barriers and facilitators to oral pre-exposure prophylaxis uptake among adolescents girls and young women at elevated risk of HIV acquisition in Lilongwe, Malawi: A qualitative study
Stephen W. Nicholas, Maureen Matewere, Agatha Bula, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004006-e0004006
Open Access
The PrEP Pharmacy Reach Study: Protocol for the creation of maps to visualize the impact of expanding access to HIV prevention services through pharmacies (Preprint)
Kristin R V Harrington, Caitlin Hamilton, Daniel I. Alohan, et al.
(2025)
Closed Access
Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness
Angela R. Bazzi, Leah C. Shaw, Katie B. Biello, et al.
Journal of General Internal Medicine (2022) Vol. 38, Iss. 4, pp. 913-921
Open Access | Times Cited: 18
Facilitators and barriers to community pharmacy PrEP delivery: a scoping review
China Harrison, Hannah Family, Joanna M Kesten, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 3
Exploring adolescent girls and young women's PrEP‐user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa
Elzette Rousseau, Kathleen J. Sikkema, Robin Julies, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 3
Pharmacist role in addressing health disparities—Part 2: Strategies to move toward health equity
Sharmon P. Osae, Daniel B. Chastain, Henry N. Young
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2022) Vol. 5, Iss. 5, pp. 541-550
Closed Access | Times Cited: 13
A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics
Monica Fadanelli, Hannah L. F. Cooper, Patricia R. Freeman, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment
Melissa Latigo Mugambi, Ben Odhiambo, Annabell Dollah, et al.
Journal of the International AIDS Society (2024) Vol. 27, Iss. S1
Open Access | Times Cited: 2
A Retrospective Comparison of HIV Pre-exposure Prophylaxis (PrEP) Outcomes Between a Pharmacist-led Telehealth Clinic and In-person Clinic in a Veteran Population
K. Fern Greenwell, Randolph V. Fugit, Lindsay Nicholson, et al.
AIDS and Behavior (2023) Vol. 27, Iss. 11, pp. 3678-3686
Open Access | Times Cited: 6
Examining pharmacies’ ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States
Daniel I. Alohan, Gabrielle Evans, Travis Sanchez, et al.
Journal of the American Pharmacists Association (2022) Vol. 63, Iss. 2, pp. 547-554
Open Access | Times Cited: 9
Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation
Gabriel A. Wagner, Kuan‐Sheng Wu, Christy M. Anderson, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review
Michael R. Gionfriddo, Katelyn M. Owens, Sarah E. Leist, et al.
Journal of the American Pharmacists Association (2023) Vol. 63, Iss. 5, pp. 1472-1489.e3
Closed Access | Times Cited: 4
Pre-exposure and postexposure prophylaxis access in rural versus urban pharmacies in Georgia and Pennsylvania
Yasaswi Kislovskiy, Natalie Pino, Natalie D. Crawford, et al.
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 4, pp. 102084-102084
Closed Access | Times Cited: 1
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States
Christina Chandra, Alexis F Hudson, Daniel I. Alohan, et al.
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 4, pp. 197-207
Closed Access | Times Cited: 1
Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019
Phillip Marotta, Kristi L. Stringer, Leo Beletsky, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Availability and accessibility of HIV self-tests and self-sample kits at community pharmacies in the Netherlands
Chaima Kandil, Jacqueline G. Hugtenburg, Titia Heijman, et al.
AIDS Research and Therapy (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Examining the Multilevel Barriers to Pharmacy-Based HIV Prevention and Treatment Services
Natalie D. Crawford, Crystal Fuller Lewis, Ronnie Moore, et al.
Sexually Transmitted Diseases (2022) Vol. 49, Iss. 11S, pp. S22-S25
Open Access | Times Cited: 4
Global engagement of pharmacists in test and treat initiatives: Bringing care from clinics to communities
Dallas J. Smith, Lily McGill, David Bonilla Carranza, et al.
Journal of the American Pharmacists Association (2022) Vol. 63, Iss. 1, pp. 419-423
Open Access | Times Cited: 4
Psychometric evaluation of the Health Care Provider HIV/AIDS Stigma Scale (HPASS) using Rasch analysis
Swarnali Goswami, Marie Barnard, Leigh Ann Bynum, et al.
Currents in Pharmacy Teaching and Learning (2022) Vol. 14, Iss. 9, pp. 1143-1153
Closed Access | Times Cited: 3
Not the Mobile Van! Antiretroviral Delivery Preferences Among Young Black Sexual Minority Men Along a Status-Neutral HIV Care Continuum
Jade Pagkas-Bather, Alicia Dawdani, Darnell Motley, et al.
Sexuality Research and Social Policy (2024)
Closed Access
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
Amber R. Douglass, Ashley J. Maister, Karen E. Moeller, et al.
Mental Health Clinician (2024) Vol. 14, Iss. 4, pp. 253-266
Open Access
Page 1 - Next Page

Scroll to top